APC anti-human CD51 [NKI-M9]
State & local contract award Virginia Awarded
- Contract number
- A207_PO-0417154-V2
- Awardee
- BIOLEGEND INC.
- Contracting organization
- University of Virginia
- Cumulative value
- $66.50
About this award
The University of Virginia awarded contract A207_PO-0417154-V2 to BioLegend Inc. on August 17, 2026, with a cumulative contract value of $66.00. The contract encompasses the delivery of one unit of APC anti-human CD51 [NKI-M9], a research reagent, at a unit price of $66.50. The deliverable is designated for Xiaoqiong Wei at the University of Virginia in Virginia.
This procurement represents a straightforward purchase of a specialized biological research product for use within the Virginia institution. The contract documents do not specify an explicit period of performance or distinct place of performance separate from the contracting organization; however, the award date of August 17, 2026, establishes the transaction timeline. As a research-grade monoclonal antibody reagent, the CD51 antibody product falls within the scientific supplies category commonly procured by academic medical and research institutions.
Line items
| Item | Total |
|---|---|
| APC anti-human CD51 [NKI-M9] | $66.50 |
Award details come from logi.cgieva.com. Updated .
Quick answers
Who was awarded contract A207_PO-0417154-V2?
Contract A207_PO-0417154-V2 was awarded to BIOLEGEND INC. by University of Virginia on August 17, 2026.
How much is contract A207_PO-0417154-V2 worth?
Its cumulative value is $66.50.
On GovTribe
See this award's full record
- Every line item and file
- The contract it was ordered under and its other orders
- Similar state and local awards and opportunities
- Ask GovTribe AI about this award